Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-02-13 @ 12:29 PM
Study NCT ID:
NCT03692767
Status:
UNKNOWN
Last Update Posted:
2019-01-30
First Post:
2018-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma
Sponsor:
Allife Medical Science and Technology Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CD22 CAR NK-BJZL-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None